CINECA IRIS Institutional Research Information System

GASCO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.842
EU - Europa 7.038
AS - Asia 3.116
AF - Africa 80
SA - Sud America 43
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 17
Totale 20.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.683
CN - Cina 1.788
DE - Germania 1.093
IT - Italia 976
SE - Svezia 951
IE - Irlanda 858
UA - Ucraina 673
FR - Francia 543
GB - Regno Unito 473
FI - Finlandia 464
SG - Singapore 366
KR - Corea 359
AT - Austria 290
VN - Vietnam 265
PL - Polonia 260
CA - Canada 150
DK - Danimarca 147
IN - India 111
RU - Federazione Russa 72
JP - Giappone 65
BE - Belgio 61
SN - Senegal 52
TW - Taiwan 50
GR - Grecia 41
NL - Olanda 39
ES - Italia 31
AU - Australia 27
BR - Brasile 25
TR - Turchia 21
EU - Europa 17
HK - Hong Kong 16
CH - Svizzera 15
EG - Egitto 15
IR - Iran 14
UZ - Uzbekistan 14
RO - Romania 10
MX - Messico 9
NZ - Nuova Zelanda 9
BG - Bulgaria 8
JO - Giordania 8
CL - Cile 7
NO - Norvegia 7
MU - Mauritius 6
HR - Croazia 5
HU - Ungheria 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
MY - Malesia 4
PK - Pakistan 4
ZA - Sudafrica 4
CO - Colombia 3
CY - Cipro 3
IL - Israele 3
IQ - Iraq 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
AM - Armenia 2
EC - Ecuador 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
IM - Isola di Man 1
LB - Libano 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 20.173
Salva come PNG Salva come JPEG
Città #
Chandler 1.347
Ann Arbor 1.120
Beijing 1.080
Dublin 853
Fairfield 677
Ashburn 484
Jacksonville 435
Houston 367
Dearborn 363
Woodbridge 363
Villeurbanne 305
Wilmington 302
Seattle 297
Vienna 285
Princeton 278
Torino 264
Medford 255
Nyköping 255
Warsaw 253
Singapore 239
Dong Ket 223
Cambridge 216
Pisa 190
Frankfurt am Main 171
Munich 106
Fremont 101
Redwood City 99
Milan 92
Boston 86
Boardman 74
Shanghai 69
Guangzhou 65
Nanjing 61
Brussels 58
Hangzhou 52
Santa Clara 52
Verona 51
Ottawa 45
Toronto 45
Taipei 42
Falls Church 41
Helsinki 41
Norwalk 41
San Diego 37
Shenyang 35
Lachine 33
Hefei 31
Zhengzhou 30
Düsseldorf 28
Washington 28
New York 27
Pune 25
Jinan 24
Turin 21
Kharkiv 20
Kunming 20
Monmouth Junction 20
Phoenix 20
Philadelphia 19
Tokyo 19
Wuhan 18
Nürnberg 17
Chengdu 16
Nanchang 16
Siena 16
Toledo 15
Silver Spring 14
Hebei 13
Nuremberg 13
Rome 13
Lansing 12
Los Angeles 12
Nottingham 12
Cairo 11
Changsha 11
Copenhagen 11
Leinì 11
Mountain View 11
Xian 11
Bologna 10
Des Moines 9
Fuzhou 9
Tianjin 9
Ardabil 8
Buffalo 8
Dallas 8
London 8
Tappahannock 8
West Jordan 8
Cardiff 7
Catania 7
Florence 7
Leawood 7
Naples 7
Dresden 6
Latina 6
San Mateo 6
Upper Marlboro 6
Amman 5
Berlin 5
Totale 12.687
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 520
1,2,5-Oxadiazole analogues of leflunomide and related compounds 433
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 405
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 343
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 304
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance 286
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 282
New furoxan derivatives for the treatment of ocular hypertension 274
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 264
Doxorubicin-antioxidant multitarget drugs 256
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 255
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 250
New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold 237
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 226
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 213
Edaravone derivatives containing NO-donor functions 209
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 200
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues 192
1,4-Dihydropyridines containing R-NNO-azoxy moieties 190
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 190
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein 173
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 170
New nitric oxide or hydrogen sulfide releasing aspirins 164
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 160
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 157
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 156
Combination of PDT and NOPDT with a tailored BODIPY derivative 153
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 151
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 147
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 147
Composti ibridi per il trattamento della malaria cerebrale 145
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. 145
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 142
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 142
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 138
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 131
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 130
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 130
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells 129
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 128
A new class of NO-donor H3-Antagonists 126
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 126
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 125
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 125
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 123
Amphiphilic NO-Donor Antioxidants 123
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 121
Multitarget Drugs: Focus on the NO-donor hybrid drugs 118
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents 117
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 117
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 116
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 116
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni 112
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 110
NO-donors: focus on furoxan derivatives 109
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 109
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 107
Carnosine analogues containing Phenol substructures 107
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 104
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 104
Inhibition of Human Placenta Glutathione Transferase P1-1 by the Antibiotic Calvatic Acid and its Diazocyanide Analogue: Evidence for Multiple Catalytic Intermediates 103
New potential uroselective NO-donor a1-antagonists 101
Activité contre les Microorganismes de dex Pyrazolyldiazène carbonitriles Oxyde-2 100
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 100
Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets. 97
A new furoxan NO-donor rabeprazole derivative and related compounds 97
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 96
A new class of ibuprofen derivatives with reduced gastrotoxicity 96
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 96
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 95
Synthesis and pharmacological characterisation of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities. 95
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 95
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 94
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 93
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 93
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents 91
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity 91
Activity of calvatic acid and its analogs against Helicobacter pylori 90
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 90
DNA-targeted NO release photoregulated by green light 90
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 89
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 88
A Directed Synthesis of Alkyl, Aryl, and Heteroaryl-ONN-azoxycyanides 88
Unsymmetrically Substituted Furoxans. VII. A 13C NMR Study of a Series of Isomeric Pairs of Furoxans and the Structure of the two Isomeric Chlorophenyl furoxans 88
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 85
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 85
13C and 15N Solution and Solid-state Nuclear Magnetic Resonance Study of the Intermolecular interactions in the 1:1 Trimethoprim:Sulphamethoxazole Complex 84
Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids 83
Furoxan derivatives as NO-donors 83
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY 83
Oximation of Acetyl(hydroxyimino)acetone: Nuclear Magnetic Resonance Spectroscopic, Chemical, and X-Ray Crystallographic Studies of the Reaction Products 83
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 82
Pharmacochemistry of the Furoxan Ring : Recent Developments 82
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 82
Studies on New Basic NO-Donor 1,4-Dihydropyridines 81
Novel Organic Nitrate Esters 81
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 81
Glutathione potentiates cGMP synthesis induced by the two phenylfuroxancarbonitrile isomers in RFL-6 cells. 81
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 81
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 79
Totale 14.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.263
article - articoli 0
book - libri 0
conference - conferenze 7.878
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.127 0 0 230 354 254 497 410 193 388 367 237 197
2020/20212.297 211 159 167 107 175 141 154 119 345 193 139 387
2021/20223.161 153 131 175 248 231 68 292 212 103 307 648 593
2022/20233.662 446 364 105 380 280 882 400 207 321 83 119 75
2023/20241.398 171 223 102 75 115 194 51 56 17 84 101 209
2024/2025385 56 275 54 0 0 0 0 0 0 0 0 0
Totale 20.887